Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
7.5 Secondary Outcomes - Glycemia, Blood Pressure, Tolerability HbA1c (T2D and obesity+T2D populations)
The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lillys tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs
ERK1/2 & VEGFR2 Mechanism Musculoskeletal Scoping Review (PMC, 2025) A 2025 scoping review confirmed BPC-157 activates VEGFR2 and drives nitric oxide synthesis via the Akt-eNOS axis, promoting angiogenesis, fibroblast activity, and neuromuscular stabilisation
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
BPC-157 initiated significant healing responses in as little as 5 days in multiple rodent models, with continued tissue regeneration over a 4-week window. Sikiric, P
Hypoglycemia occurs when blood sugar levels drop below 70 mg/dL or 3.9 mmol/L
US$ 29.34
US$ 23.40
US$ 28.94
US$ 25.93
US$ 25.60
